Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, January 2000

Sort by: Newest first Oldest first A-Z Z-A

  • Major trial of medicines management

    29 JAN 2000 0:00

    A major, nationwide trial of medicines management is soon to take place in England. The editor of The Pharmaceutical Journal (Mr Douglas Simpson) asked Mr Allen Tweedie (the chairman of the profession’s leadership group on medicines management, right) to describe the trial and to explain what he hopes the trial will achieve

  • Pharmacy in Macedonia Subscription

    29 JAN 2000 0:00 By Pamela Mason
    Rating  Star Rating 5

    Pamela Mason reports on health care provision in Macedonia

  • Training pays off for expanding chain

    29 JAN 2000 0:00

    The Day Lewis pharmacy chain, headed by the current National Pharmaceutical Association chairman, Kirit Patel, is expanding along the east and south coasts of England. The Journal visited Sevenoaks, Kent, recently to speak to Mr Patel

  • Apples may improve lung function, researchers say

    29 JAN 2000 0:00

    Eating five or more apples each week may improve lung function, a study suggests. Ms Barbara Butland (department of public health sciences, St Georges medical school, London) and colleagues say that “a strong positive association is seen between lung function and the number of apples eaten per week”. This protective effect was not observed with soft or citrus fruit.

  • Bronchospasm associated with Relenza

    29 JAN 2000 0:00

    Zanamivir (Relenza) should be used with “special caution” in patients with asthma or chronic obstructive pulmonary disease (COPD), according to an advisory letter sent to all physicians by the manufacturer, Glaxo Wellcome.

  • Docetaxel colitis

    29 JAN 2000 0:00

    Colitis may result from chemotherapy with docetaxel, according to Dr Nuhad Ibrahim (department of breast medical oncology, University of Texas, US) and colleagues. They report six cases of ischaemic colitis associated with docetaxel-based therapy in clinical trial patients (Lancet 2000;355:281).

  • Herbal medicine interactions

    29 JAN 2000 0:00

    Herbs may mimic, magnify or oppose the effects of conventional medicines if taken concurrently, says Dr Adriane Fugh-Berman (George Washington university school of medicine, Washington, US). In a review article in the Lancet, he describes documented herb-induced interactions (2000;355:134).

  • HOPE study published

    29 JAN 2000 0:00

    The Heart Outcomes Prevention Evaluation (HOPE) study has been published in both the New England Journal of Medicine (2000;342:145) and the Lancet (2000;355:253). The study results, which show that the ACE inhibitor ramipril reduces the likelihood of cardiovascular events in high-risk patients by 22 per cent, were first made available on the NEJM website (www.nejm.org) last November “because of the potential therapeutic ...

  • New infertility guidelines published

    29 JAN 2000 0:00

    Guidelines on management of infertility in tertiary care were issued by the Royal College of Obstetricians and Gynaecologists this month. The evidence-based guidelines contain 42 recommendations for practice, the cost consequences of which are likely to be mixed, they say.

  • High meningitis C vaccine uptake

    29 JAN 2000 0:00

    Uptake of the meningitis C vaccine has been high, announced Ms Jane Hutt, the Welsh Assembly Health and Social Services Secretary, on January 19. “The uptake of the vaccine has been between 80 and 90 per cent, which is a good figure, and I am pleased that so many of those targeted have taken the opportunity to be vaccinated,” she said. The immunisation of 15 to 17 year-olds is now largely complete and that of two-, three- and four-month-old babies is continuing. Vaccination has been ...

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.